Invention Grant
US08815847B2 [1,2,4]thiadiazine 1,1-dioxide compounds for lowering serum uric acid
有权
[1,2,4]噻二嗪1,1-二氧化物,用于降低血清尿酸
- Patent Title: [1,2,4]thiadiazine 1,1-dioxide compounds for lowering serum uric acid
- Patent Title (中): [1,2,4]噻二嗪1,1-二氧化物,用于降低血清尿酸
-
Application No.: US13490046Application Date: 2012-06-06
-
Publication No.: US08815847B2Publication Date: 2014-08-26
- Inventor: James L. Freddo
- Applicant: James L. Freddo
- Applicant Address: US CA South San Francisco
- Assignee: Anadys Pharmaceuticals, Inc.
- Current Assignee: Anadys Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Womble Carlyle Sandridge & Rice
- Main IPC: A61K31/54
- IPC: A61K31/54
![[1,2,4]thiadiazine 1,1-dioxide compounds for lowering serum uric acid](/abs-image/US/2014/08/26/US08815847B2/abs.jpg.150x150.jpg)
Abstract:
The present invention describes [1,2,4]thiadiazine 1,1-dioxide compounds and pharmaceutically acceptable salts thereof, which are useful in lowering serum uric acid in a patient in need thereof comprising administering to the patient a therapeutically or prophylactically effective amount of a [1,2,4]thiadiazine 1,1-dioxide compound.
Public/Granted literature
- US20120316156A1 [1,2,4]THIADIAZINE 1,1-DIOXIDE COMPOUNDS FOR LOWERING SERUM URIC ACID Public/Granted day:2012-12-13
Information query